The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Neuroblastoma Treatment-Global Market Insights and Sales Trends 2025
Synopsis
Neuroblastoma treatment includes medical interventions and therapies used to manage neuroblastoma, a type of cancer that affects the sympathetic nervous system, typically occurring in young children.
The global Neuroblastoma Treatment market size is expected to reach US$ 566.7 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of Neuroblastoma Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Neuroblastoma Treatment market. Combination Chemotherapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Monoclonal Antibody Therapy segment is estimated at % CAGR for the next seven-year period.
The market for neuroblastoma treatment is driven by the need for effective and personalized therapies to improve survival rates and long-term outcomes for pediatric cancer patients. The market's growth is also influenced by ongoing research in neuroblastoma therapeutics and the development of targeted and immunotherapeutic approaches.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neuroblastoma Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neuroblastoma Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neuroblastoma Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neuroblastoma Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neuroblastoma Treatment covered in this report include Seattle Children’s, CureSearch, Texas Children’s, NANT, Sino Biopharmaceutical, Jiangsu Hengrui Medicine Co.,Ltd., Fosun Pharmaceutical, Novartis and Juno Therapeutics, etc.
The global Neuroblastoma Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Seattle Children’s
CureSearch
Texas Children’s
NANT
Sino Biopharmaceutical
Jiangsu Hengrui Medicine Co.,Ltd.
Fosun Pharmaceutical
Novartis
Juno Therapeutics
Kite Pharma
Adaptimmune
Global Neuroblastoma Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neuroblastoma Treatment market, Segment by Type:
Combination Chemotherapy
Monoclonal Antibody Therapy
Vaccine Therapy
Chimeric Antigen Receptor T-Cell Immunotherapy
Oncolytic Virus Therapy
Global Neuroblastoma Treatment market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Neuroblastoma Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Neuroblastoma treatment includes medical interventions and therapies used to manage neuroblastoma, a type of cancer that affects the sympathetic nervous system, typically occurring in young children.
The global Neuroblastoma Treatment market size is expected to reach US$ 566.7 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of Neuroblastoma Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Neuroblastoma Treatment market. Combination Chemotherapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Monoclonal Antibody Therapy segment is estimated at % CAGR for the next seven-year period.
The market for neuroblastoma treatment is driven by the need for effective and personalized therapies to improve survival rates and long-term outcomes for pediatric cancer patients. The market's growth is also influenced by ongoing research in neuroblastoma therapeutics and the development of targeted and immunotherapeutic approaches.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neuroblastoma Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neuroblastoma Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neuroblastoma Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neuroblastoma Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neuroblastoma Treatment covered in this report include Seattle Children’s, CureSearch, Texas Children’s, NANT, Sino Biopharmaceutical, Jiangsu Hengrui Medicine Co.,Ltd., Fosun Pharmaceutical, Novartis and Juno Therapeutics, etc.
The global Neuroblastoma Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Seattle Children’s
CureSearch
Texas Children’s
NANT
Sino Biopharmaceutical
Jiangsu Hengrui Medicine Co.,Ltd.
Fosun Pharmaceutical
Novartis
Juno Therapeutics
Kite Pharma
Adaptimmune
Global Neuroblastoma Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neuroblastoma Treatment market, Segment by Type:
Combination Chemotherapy
Monoclonal Antibody Therapy
Vaccine Therapy
Chimeric Antigen Receptor T-Cell Immunotherapy
Oncolytic Virus Therapy
Global Neuroblastoma Treatment market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Neuroblastoma Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Neuroblastoma Treatment
1.1 Neuroblastoma Treatment Market Overview
1.1.1 Neuroblastoma Treatment Product Scope
1.1.2 Neuroblastoma Treatment Market Status and Outlook
1.2 Global Neuroblastoma Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Neuroblastoma Treatment Market Size by Region (2018-2029)
1.4 Global Neuroblastoma Treatment Historic Market Size by Region (2018-2023)
1.5 Global Neuroblastoma Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Neuroblastoma Treatment Market Size (2018-2029)
1.6.1 North America Neuroblastoma Treatment Market Size (2018-2029)
1.6.2 Europe Neuroblastoma Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Neuroblastoma Treatment Market Size (2018-2029)
1.6.4 Latin America Neuroblastoma Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Neuroblastoma Treatment Market Size (2018-2029)
2 Neuroblastoma Treatment Market by Type
2.1 Introduction
2.1.1 Combination Chemotherapy
2.1.2 Monoclonal Antibody Therapy
2.1.3 Vaccine Therapy
2.1.4 Chimeric Antigen Receptor T-Cell Immunotherapy
2.1.5 Oncolytic Virus Therapy
2.2 Global Neuroblastoma Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Neuroblastoma Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Neuroblastoma Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Neuroblastoma Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Neuroblastoma Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Neuroblastoma Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Neuroblastoma Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Neuroblastoma Treatment Revenue Breakdown by Type (2018-2029)
3 Neuroblastoma Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Neuroblastoma Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Neuroblastoma Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Neuroblastoma Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Neuroblastoma Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Neuroblastoma Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Neuroblastoma Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Neuroblastoma Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Neuroblastoma Treatment Revenue Breakdown by Application (2018-2029)
4 Neuroblastoma Treatment Competition Analysis by Players
4.1 Global Neuroblastoma Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuroblastoma Treatment as of 2022)
4.3 Date of Key Players Enter into Neuroblastoma Treatment Market
4.4 Global Top Players Neuroblastoma Treatment Headquarters and Area Served
4.5 Key Players Neuroblastoma Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Neuroblastoma Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Seattle Children’s
5.1.1 Seattle Children’s Profile
5.1.2 Seattle Children’s Main Business
5.1.3 Seattle Children’s Neuroblastoma Treatment Products, Services and Solutions
5.1.4 Seattle Children’s Neuroblastoma Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Seattle Children’s Recent Developments
5.2 CureSearch
5.2.1 CureSearch Profile
5.2.2 CureSearch Main Business
5.2.3 CureSearch Neuroblastoma Treatment Products, Services and Solutions
5.2.4 CureSearch Neuroblastoma Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 CureSearch Recent Developments
5.3 Texas Children’s
5.3.1 Texas Children’s Profile
5.3.2 Texas Children’s Main Business
5.3.3 Texas Children’s Neuroblastoma Treatment Products, Services and Solutions
5.3.4 Texas Children’s Neuroblastoma Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 NANT Recent Developments
5.4 NANT
5.4.1 NANT Profile
5.4.2 NANT Main Business
5.4.3 NANT Neuroblastoma Treatment Products, Services and Solutions
5.4.4 NANT Neuroblastoma Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 NANT Recent Developments
5.5 Sino Biopharmaceutical
5.5.1 Sino Biopharmaceutical Profile
5.5.2 Sino Biopharmaceutical Main Business
5.5.3 Sino Biopharmaceutical Neuroblastoma Treatment Products, Services and Solutions
5.5.4 Sino Biopharmaceutical Neuroblastoma Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Sino Biopharmaceutical Recent Developments
5.6 Jiangsu Hengrui Medicine Co.,Ltd.
5.6.1 Jiangsu Hengrui Medicine Co.,Ltd. Profile
5.6.2 Jiangsu Hengrui Medicine Co.,Ltd. Main Business
5.6.3 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Products, Services and Solutions
5.6.4 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
5.7 Fosun Pharmaceutical
5.7.1 Fosun Pharmaceutical Profile
5.7.2 Fosun Pharmaceutical Main Business
5.7.3 Fosun Pharmaceutical Neuroblastoma Treatment Products, Services and Solutions
5.7.4 Fosun Pharmaceutical Neuroblastoma Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Fosun Pharmaceutical Recent Developments
5.8 Novartis
5.8.1 Novartis Profile
5.8.2 Novartis Main Business
5.8.3 Novartis Neuroblastoma Treatment Products, Services and Solutions
5.8.4 Novartis Neuroblastoma Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Novartis Recent Developments
5.9 Juno Therapeutics
5.9.1 Juno Therapeutics Profile
5.9.2 Juno Therapeutics Main Business
5.9.3 Juno Therapeutics Neuroblastoma Treatment Products, Services and Solutions
5.9.4 Juno Therapeutics Neuroblastoma Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Juno Therapeutics Recent Developments
5.10 Kite Pharma
5.10.1 Kite Pharma Profile
5.10.2 Kite Pharma Main Business
5.10.3 Kite Pharma Neuroblastoma Treatment Products, Services and Solutions
5.10.4 Kite Pharma Neuroblastoma Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Kite Pharma Recent Developments
5.11 Adaptimmune
5.11.1 Adaptimmune Profile
5.11.2 Adaptimmune Main Business
5.11.3 Adaptimmune Neuroblastoma Treatment Products, Services and Solutions
5.11.4 Adaptimmune Neuroblastoma Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 Adaptimmune Recent Developments
6 North America
6.1 North America Neuroblastoma Treatment Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Neuroblastoma Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Neuroblastoma Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Neuroblastoma Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Neuroblastoma Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Neuroblastoma Treatment Market Dynamics
11.1 Neuroblastoma Treatment Industry Trends
11.2 Neuroblastoma Treatment Market Drivers
11.3 Neuroblastoma Treatment Market Challenges
11.4 Neuroblastoma Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
